Who invested in Re-Vana Therapeutics?
Re-Vana Therapeutics's investors include Visionary Ventures, MassChallenge, SyndicateRoom, Techstart Ventures and ExSight Ventures. Visionary Ventures led its latest round.

United Kingdom · Series A startup
Funding summaryUpdated 26 Oct 2026
$12Mraised across 1 round since 2022, from 2 sources
Reported by Firms' own news pages and 1 other
Re-Vana Therapeutics's investors include Visionary Ventures, MassChallenge, SyndicateRoom, Techstart Ventures and ExSight Ventures. Visionary Ventures led its latest round.
Re-Vana Therapeutics has raised $12M across 1 round since 2022.
Re-Vana Therapeutics's most recent round was a Series A of $12M in Nov 2022, led by Visionary Ventures.
Its most recent round, $12M in Nov 2022, is also its largest on record.
Re-Vana Therapeutics's first round on record, in Nov 2022, was backed by Visionary Ventures, MassChallenge and SyndicateRoom and 2 others.
Re-Vana Therapeutics's latest named round is a Series A, in Nov 2022.
Re-Vana Therapeutics is based in the United Kingdom.
Visionary Ventures led the Series A in 2022.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.